Placebo News and Research

RSS

Taking parathyroid hormone followed by a year on alendronate shows strong osteoporosis benefit

Postmenopausal women who took a bone-building drug for one year followed by a year on a standard drug that fights bone loss experienced greater increases in bone density than has been reported from any other drug regimen, an NIH-sponsored study has found. Bone density is the standard predictor of fracture risk associated with osteoporosis.

11 Aug 2005

$Experts predict that bone fractures will become a bigger and more costly problem$

Experts predict that bone fractures will become a bigger and more costly problem

With an aging population, and with people living longer, experts say bone fractures will become a bigger and more costly problem unless more is done to prevent them.

9 Aug 2005

Supplements of multivitamins and minerals don't prevent infections in the elderly

Researchers at the University of Aberdeen in Scotland, say giving daily supplements of multivitamins and minerals do not prevent respiratory, stomach, skin and other types of infections in the elderly.

8 Aug 2005

Switching treatment to the drug anastrozole after two years of tamoxifen is beneficial for women with early breast cancer

Switching treatment to the drug anastrozole after two years of tamoxifen can improve eventfree survival for postmenopausal women with early breast cancer, concludes a study in this week’s issue of The Lancet.

4 Aug 2005

Multivitamins don't prevent infections in older people

Multivitamin and mineral supplements don't appear to prevent infections in older people living at home, finds a study in this week's British Medical Journal (BMJ).

4 Aug 2005

MediciNova starts phase II clinical trial of MN-166 for multiple sclerosis

MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.

2 Aug 2005

Acupuncture is an effective treatment for tension headache

And a minimal acupuncture course works almost as well as traditional Chinese therapy, say the researchers.

28 Jul 2005

Echinacea little use in relieving colds

According to a new study by the University of Virginia School of Medicine, taking the the herbal remedy Echinacea, to relieve the symptoms of the common cold, is a waste of time and offers no more relief than a placebo.

28 Jul 2005

First trial of pramipexole for the treatment of fibromyalgia

The mechanism of fibromyalgia, a chronic illness characterized by muscle pain, fatigue, and sleep disturbances, is unknown and medications used to treat it (such as antidepressants, antiepileptics, muscle relaxants, antiinflammatories, sedative hypnotics, pain relievers and nutriceuticals) have had limited success.

28 Jul 2005

Testosterone patch makes older women feel sexy

Women who experience a reduction in sexual desire after the surgical removal of the ovaries, can now be treated with a patch containing the hormone testosterone in order to increase sexual desire and activity.

27 Jul 2005

Opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant

Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.

26 Jul 2005

Potential new treatment for nerve damage caused by diabetes

Research into a new treatment for nerve damage caused by diabetes could bring relief to millions of diabetic patients, say experts.

From The University of Manchester 26 Jul 2005

Analysis of the Phase I/II clinical trial of HIV drug candidate PA-457

V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.

26 Jul 2005

Investigational vaccine against Clostridium difficile

Acambis has announced that earlier this month it started a Phase I clinical trial of its investigational vaccine against Clostridium difficile (C. difficile).

26 Jul 2005

Vitamin D supplementation does not appear to prevent bone loss in postmenopausal black women

Although there is general agreement on the optimal calcium intake recommended for reducing postmenopausal bone loss, and it is recognized that vitamin D is important in calcium maintenance, the optimal intake of vitamin D is controversial, according to background information in the article.

25 Jul 2005

Testosterone patch may produce modest increases in sexual desire

A testosterone patch may produce modest increases in sexual desire and frequency of satisfying sexual experiences in women who develop distressful, low sexual desire following hysterectomy and removal of the fallopian tubes and ovaries, according to a study in the July 25 issue of Archives of Internal Medicine.

25 Jul 2005

Stress test has less effect on blood vessels when hormone cortisol is blocked

Negative effects of the hormone cortisol on the inner lining of blood vessels, the endothelium, may explain how stressful events trigger heart attacks and other cardiovascular problems, according to a new study in the July 19, 2005, issue of the Journal of the American College of Cardiology.

21 Jul 2005

Imiquimod and fluorouracil emerge as effective weapons for treating superficial basal cell carcinomas

Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.

21 Jul 2005

Biologic treatments to treat the physical symptoms of psoriasis

More than 4.5 million adults in the United States have been diagnosed with psoriasis and 21 percent of those have moderate to severe psoriasis. This chronic condition, characterized by thick, red, scaly plaques that itch and bleed, not only makes the activities of daily life difficult, but also can affect a person's emotional well being.

21 Jul 2005

Metformin should be in the first line of defense against type 2 diabetes

A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes. Using metformin alone can improve control of blood glucose, while also reducing risk factors for heart disease such as excess body weight, cholesterol levels and hypertension, the review found.

20 Jul 2005